University Hospital Basel,
Tentative title: T Cell directed cancer immunotherapy
Alfred Zippelius, MD, is Co-Head of the Department of Medical Oncology at the University Hospital Basel and is Professor of Translational Oncology at the Department of Biomedicine, University Basel. He completed his oncology residency training at the University Hospitals of Munich, Lausanne and Zurich, and performed postdoctoral trainings at the University Chicago and the Ludwig Center Research Center Lausanne. His clinical focus is dedicated to the care of patients with lung cancer and advanced melanoma. He is conducting clinical trials as well as supervising clinical and basic research in his laboratory focusing on translational research in the area of cancer immunotherapy with a special focus on T cell directed and combination therapies. Dr. Zippelius` research work is supported by international and national grants, he is section editor of JITC and serves on the scientific advisory boards for national funding bodies and companies.